Taris Biomedical closes enrollment in phase Ib trial for drug-device combo Submitted by admin on Sat, 01/07/2017 - 12:07 Read more about Taris Biomedical closes enrollment in phase Ib trial for drug-device combo Source Mass Device Headline Taris Biomedical closes enrollment in phase Ib trial for drug-device combo News Tags Taris drug-device combos devices gemcitabine bladder cancer
Halozyme Cancer Drug Does Well in Phase 2 Submitted by admin on Fri, 01/06/2017 - 10:13 Read more about Halozyme Cancer Drug Does Well in Phase 2 Source Investopedia Headline Halozyme Cancer Drug Does Well in Phase 2 News Tags Halozyme pancreatic cancer clinical trials PEGPH20 Eli Lilly Celgene gemcitabine Abraxane
Mylan expands recall of cancer meds made for Pfizer Submitted by admin on Tue, 06/09/2015 - 23:46 Read more about Mylan expands recall of cancer meds made for Pfizer Source Fierce Pharma Manufacturing Headline Mylan expands recall of cancer meds made for Pfizer News Tags recalls Mylan gemcitabine Pfizer
Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 Submitted by admin on Sun, 06/01/2014 - 11:35 Read more about Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with Advanced Pancreatic Cancer Presented at ASCO 2014 Source Yahoo/BusinessWire Headline Post-Hoc Analysis of Overall Survival in Phase III MPACT Study of Patients with… News Tags pancreatic cancer Abraxane gemcitabine Celgene
Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer Submitted by admin on Sun, 06/01/2014 - 11:31 Read more about Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-Labeled Clivatuzumab Tetraxetan in Patients With Metastatic Pancreatic Cancer Source Yahoo/Globe Newswire Headline Immunomedics Reports Final Efficacy Results of Phase Ib Trial With Yttrium-90-L… News Tags Immunomedics pancreatic cancer clivatuzumab tetraxetan gemcitabine